(Q42451781)

31 October 2017

Low prognostic implication of fibroblast growth factor family activation in triple-negative breast cancer subsets (English)

1 reference

triple-negative breast cancer

31 October 2017

1 reference

Hee Jin Lee

1

1 reference

31 October 2017

An Na Seo

2

1 reference

31 October 2017

So Yeon Park

3

1 reference

31 October 2017

Joo Young Kim

4

1 reference

31 October 2017

Ji Young Park

5

1 reference

31 October 2017

Jong Han Yu

6

1 reference

31 October 2017

Jin-Hee Ahn

7

1 reference

31 October 2017

Gyungyub Gong

8

1 reference

31 October 2017

3 January 2014

1 reference

Annals of Surgical Oncology

31 October 2017

1 reference

31 October 2017

21

1 reference

31 October 2017

5

1 reference

31 October 2017

1561-1568

1 reference

https://scigraph.springernature.com/pub.10.1245/s10434-013-3456-x

31 October 2017

0 references

cites work

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3456-X

Exploring molecular pathways of triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3456-X

Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3456-X

Molecular pathways: fibroblast growth factor signaling: a new therapeutic opportunity in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3456-X

Mechanisms of FGFR-mediated carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3456-X

FGFR1 amplification in breast carcinomas: a chromogenic in situ hybridisation analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3456-X

American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3456-X

FGFR1 is amplified during the progression of in situ to invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3456-X

Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3456-X

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3456-X

Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3456-X

Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3456-X

Comprehensive profiling of 8p11-12 amplification in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3456-X

FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3456-X

FGFR signaling promotes the growth of triple-negative and basal-like breast cancer cell lines both in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3456-X

Challenges and opportunities in the targeting of fibroblast growth factor receptors in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3456-X

The origins and implications of intratumor heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3456-X

10.1245/S10434-013-3456-X

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

31 October 2017

0 references

1 reference